Skip to main content
中科美菱 logo

中科美菱 — Investor Relations & Filings

Ticker · 920992 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2022-12-14 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920992

About 中科美菱

http://www.zkmeiling.com/

Zhongke Meiling Cryogenics Co., Ltd., branded as Meling Biology & Medical, specializes in the research, development, and manufacturing of low-temperature storage solutions and laboratory equipment. The product portfolio includes ultra-low temperature freezers capable of reaching -86°C and -164°C, medical refrigerators, blood bank refrigerators, and pharmacy refrigerators. The company also provides cold chain logistics equipment and biological sample bank management systems. Its technical focus centers on advanced cryogenic cooling systems designed for the preservation of biological materials, vaccines, and medical supplies. These solutions are utilized by research institutes, healthcare facilities, and pharmaceutical organizations requiring precise temperature control and long-term storage reliability.

Recent filings

Filing Released Lang Actions
关于使用部分募集资金向全资子公司增资及提供借款实施募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of part of the company's raised funds (募集资金) to increase capital and provide loans to a wholly-owned subsidiary for implementing investment projects. It includes details about the fundraising, investment projects, board and supervisory committee approvals, independent director opinions, and the involvement of the sponsor institution. The document is a formal disclosure of a financing and capital allocation decision related to the use of proceeds from a recent equity issuance. It does not contain financial statements or comprehensive financial performance data, nor is it a report or transcript. It is an update on capital use and financing activities. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 3535 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2022-12-14 Chinese
提供担保暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the provision of guarantees and related party transactions involving the company and its controlling shareholder. It includes specifics about the guarantee amount, terms, related party nature, board resolutions, and opinions from the sponsor institution. The document does not contain financial statements or comprehensive financial performance data but focuses on a specific financing-related transaction and corporate governance matters related to it. It is not an annual or interim report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about a capital/financing update involving guarantees and related party transactions. Therefore, the document best fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters but contains detailed transaction information, not just a brief notice or report publication announcement.
2022-12-14 Chinese
申万宏源证券承销保荐有限责任公司关于中科美菱低温科技股份有限公司为全资子公司提供担保的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from a securities underwriting and sponsorship company regarding a guarantee provided by Zhongke Meiling Cryogenic Technology Co., Ltd. to its wholly-owned subsidiaries. It discusses the guarantee details, approval procedures, and compliance with regulatory requirements. The document is short (1198 characters) and does not contain financial statements or detailed financial data. It is a regulatory compliance and verification statement related to a specific corporate action (providing guarantees). It does not fit into categories like Annual Report, Interim Report, or Capital/Financing Update. It is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement that does not fit other specific categories.
2022-12-14 Chinese
关于开展外汇套期保值业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 中科美菱低温科技股份有限公司 regarding the initiation of foreign exchange hedging business. It details the necessity, basic situation, risk analysis, risk control measures, and accounting principles related to the foreign exchange hedging activities. It also mentions board resolutions and shareholder meeting approvals required. The document is a formal announcement about a financing risk management activity rather than a financial report, earnings release, or regulatory certification. It does not contain financial statements or detailed financial results. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing risk management strategy and hedging activities.
2022-12-14 Chinese
关于公司使用自有闲置资金进行投资理财的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 中科美菱低温科技股份有限公司 regarding the use of its own idle funds for investment in financial products. It details the purpose, risks, and approval process of this investment but does not contain financial statements or results. It is a corporate announcement about capital usage and investment plans, not a financial report or earnings release. The document length is short (1555 characters), and it is not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and capital management.
2022-12-14 Chinese
关于使用自有资金、银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the use of self-owned funds and bank acceptance bills to pay for part of a fundraising investment project, with an equivalent replacement by raised funds. It includes details about the fundraising, investment projects, reasons for the fund usage method, approval procedures by the board and supervisory committee, independent director opinions, and sponsor institution verification. The document is a formal disclosure about the company's capital usage and fundraising fund management, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive content and explanations. The document fits best under Capital/Financing Update (CAP) as it relates to the company's fundraising capital usage and replacement procedures.
2022-12-14 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.